ArticleAnnals of medicine and surgery (2012)2025
Measles resurgence in Texas: a public health wake-up call.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Rise in Measles Reporting Two Years After the COVID-19 Pandemic: A Descriptive Analysis of Measles in Iraq in 2023 and Early 2024.International journal of environmental research and public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Measles, a highly contagious viral disease once nearing elimination in the USA, has resurged, with Texas reporting its most severe outbreak in nearly three decades. As of February 2025, over 48 confirmed cases, predominantly among unvaccinated children, highlight critical vulnerabilities in state immunization policy. Factors driving this resurgence include declining vaccination rates, widespread misinformation, legislative allowances for nonmedical exemptions, and public health disruptions from the COVID-19 pandemic. The Texas outbreak reflects a global trend, with measles cases increasing by nearly 80% in 2023 compared to pre-pandemic levels, underscoring gaps in herd immunity and the fragility of elimination gains. This article examines epidemiological features, transmission dynamics, and clinical manifestations of measles, emphasizing the severe complications and public health burden it poses. It also reviews preventive measures, ethical considerations surrounding vaccine mandates, and strategies for improving coverage, including restricting exemptions, expanding rural outreach, and combating misinformation. Without immediate, sustained interventions, Texas risks recurring outbreaks, threatening broader national measles control efforts and reversing decades of progress in vaccine-preventable disease prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.